Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAP | Q12884 | 5/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 7/20 | 0.36 |
| ▸ | SIRT2 | Q8IXJ6 | 7/20 | 0.36 |
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.34 |
| ▸ | FURIN | P09958 | 2/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.32 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13401564 | 1.00 | FAP (0.42) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL16327728 | 0.94 | FAP (0.42) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL13410094 | 0.93 | SIRT2 (0.37) | FAPSIRT1SIRT2OPRK1SIRT3 | |
| SCHEMBL13401535 | 0.93 | SIRT2 (0.37) | FAPSIRT1SIRT2OPRK1SIRT3 | |
| SCHEMBL16299921 | 0.92 | FAP (0.45) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL14012282 | 0.90 | FURIN (0.41) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL29692594 | 0.89 | FAP (0.44) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL16387730 | 0.88 | FAP (0.47) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL13410103 | 0.88 | FAP (0.44) | FAPSIRT1SIRT2MAP1LC3BFURIN | |
| SCHEMBL16350292 | 0.88 | FAP (0.44) | FAPSIRT1SIRT2MAP1LC3BFURIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7691962-B2 | Chemical linkers and conjugates thereof | MEDAREX, INC. (US) | 2010-04-06 | — | — | US | disclosed |